logo
11:54 Jun 18

Anthem Biosciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
796.85
+29.35 (+3.82%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Anthem Biosciences Ltd. Financials

Anthem Biosciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
796.85
+29.35 (+3.82%)
11:54 Jun 18
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

27/100
Expensive Valuation

Technical

57/100
Technically Neutral

Strength

15

Weakness

3

Opportunity

1

Threats

0

19.45 %

ROE %

17.25 %

ROA %

10.51

EPS

54.16

BVPS

27.85 %

Net Profit Margin

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
1056.92 1419.37 1844.55 2124.33
Operating Expenses +
628.04 914.39 1173.72 1290.53
Raw Material
348.29 640.79 830.62 713.59
Increase Decrease in Cost
-9.01 -41.24 -86.7 98.69
Other Manufacturing Expense
0 0 0 0
Employee Cost
153.24 182.93 260.49 282.7
Miscellaneous Expenses
135.52 131.91 169.31 195.55
Operating Profit
428.88 504.98 670.83 833.8
Other Income
77.07 63.7 85.73 155.78
Depreciation
63.7 81.82 89.37 134.07
Interest
6.76 9.54 10.33 6.89
Profit before tax and exceptio..
435.5 477.32 656.87 848.63
Exceptional Items
61.8 0 0 -24.39
PBT
497.3 477.32 656.87 824.24
Provision for Taxation
112.11 110.01 205.61 232.45
Net Profit
385.18 367.31 451.26 591.79
NET Profit after MI
385.18 367.31 451.26 591.79
EPS
6.75 6.48 8.04 10.43
Operating Profit Margin (%)
40.58 35.58 36.37 39.25
Net Profit Margin (%)
36.44 25.88 24.46 27.86

Anthem Biosciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: